Lou Silverman
CIK 1249935 · Chief Executive Officer · last filed 2026-07-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
STAA price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
STE 450
IRVINE, CA 92612
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Insight Molecular Diagnostics Inc. (OCX) Delisted | Director | 55,807 | $3.20 | $178.6K | $0 | 5 | 2026-07-06 |
| STAA | Director | 12,658 | $25.13 | $318.1K | -$6.86M | 16 | 2026-06-22 |
| BTX | Director | 38 | $7.42 | $282 | $0 | 4 | 2016-10-31 |
| QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted | Director | 14,183 | — | — | $0 | 8 | 2013-05-29 |
Holdings By Holder
| Symbol | Holder | Shares | Share of Total | Reported |
|---|---|---|---|---|
| STAA | Direct | 11,158 | 88.1% | 2026-06-22 |
| By Family Trust | 1,500 | 11.9% | 2021-08-12 | |
| Total | 12,658 |
Recent Filings · Page 3 of 5
41 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-08-10 | STAA | Grant (A) | — | $0 | EDGAR |
| 2016-06-27 | STAA | Grant (A) | — | $0 | EDGAR |
| 2015-08-11 | STAA | Buy (P) | +1,500 | $12.3K | EDGAR |
| 2015-07-10 | STAA | Grant (A) | +4,898 | $0 | EDGAR |
| 2015-06-19 | BTX | Grant (A) | — | $0 | EDGAR |
| 2014-09-16 | STAA | Grant (A) | +11,763 | $0 | EDGAR |
| 2014-08-18 | — | Disp (D) | −24,183 | $0 | |
| 2013-10-10 | BTX | Grant (A) | +75,000 | $0 | EDGAR |
| 2013-05-29 | QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted | Grant (A) | +4,183 | $0 | EDGAR |
| 2012-08-02 | BTX | Grant (A) | — | $0 | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).